Home › NDC Lookup › RxCUI directory › RxCUI 1052684

Pramoxine hydrochloride 10 MG/ML Topical Cream — RxCUI 1052684

RxNorm drug concept · Semantic clinical drug
RxCUI 1052684 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1052684
Official namePramoxine hydrochloride 10 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspramoxine hydrochloride 1 % Topical Cream; pramoxine HCl 1 % Topical Cream
FDA products mapped5
Package NDCs mapped9
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pramoxine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Pramoxine is a local anesthetic, which means it temporarily numbs the area where you apply it. It works right at the skin's surface to block the sensation of pain and itching. It d...
  • What exactly does pramoxine do — how does it stop the itching?
  • It depends on which product you have. Most creams, sprays, and solutions are used up to 3 to 4 times daily. Some products, like Proctofoam for the rectal area, can be used up to 5...
  • No. All pramoxine products are for external use only — that means the outside of the skin. Even products intended for the genital or rectal area, like the Terramed Intimate Wash or...
📖 Read our full Pramoxine guide →

🕸️ Concept Web — How Pramoxine hydrochloride 10 MG/ML Topical Cream Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pramoxine hydrochloride 10 MG/ML Topical Cream RxCUI 1052684

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Pramoxine 34347
    • Pramoxine hydrochloride 57555
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Eczemin 1233204
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pramoxine Topical Cream 377923
    • Pramoxine hydrochloride Topical Cream 2645497
    • Pramoxine Topical Product 1165744
    • Pramoxine hydrochloride Topical Product 2662904
    • Pramoxine Topical Cream [Eczemin] 1233206
    • Pramoxine hydrochloride Topical Cream [Eczemin] 2657841
    • Eczemin Topical Product 1233207
    • Topical Cream 316982
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Pramoxine hydrochloride 10 MG/ML 828361
    • Pramoxine hydrochloride 10 MG/ML Topical Cream [Eczemin] 1233208
    • Pramoxine hydrochloride 10 MG/ML [Eczemin] 1233205

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pramoxine hydrochloride 10 MG/ML SCDC · 828361
  • Pramoxine Topical Cream SCDF · 377923
  • Pramoxine hydrochloride Topical Cream SCDFP · 2645497
  • Pramoxine Topical Product SCDG · 1165744
  • Pramoxine hydrochloride Topical Product SCDGP · 2662904

Brand-Name Concepts

  • Pramoxine hydrochloride 10 MG/ML Topical Cream [Eczemin] SBD · 1233208
  • Pramoxine hydrochloride 10 MG/ML [Eczemin] SBDC · 1233205
  • Pramoxine Topical Cream [Eczemin] SBDF · 1233206
  • Pramoxine hydrochloride Topical Cream [Eczemin] SBDFP · 2657841
  • Eczemin Topical Product SBDG · 1233207
  • Eczemin BN · 1233204

📦 FDA Products & Package NDCs

5 products · 9 package NDCs
9 package NDCs map to RxCUI 1052684 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24330-0130-02 1 TUBE in 1 BOX (24330-130-02) / 21 g in 1 TUBE First Degree Maximum Strength Burn Welmedix LLC 2017-03-09
49967-0512-01 340 g in 1 JAR (49967-512-01) CeraVe Developed with Dermatologists Itch Relief Moisturizing L'Oreal USA Products Inc 2017-09-18
49967-0512-02 453.6 g in 1 JAR (49967-512-02) CeraVe Developed with Dermatologists Itch Relief Moisturizing L'Oreal USA Products Inc 2017-09-18
49967-0512-03 538.6 g in 1 JAR (49967-512-03) CeraVe Developed with Dermatologists Itch Relief Moisturizing L'Oreal USA Products Inc 2017-09-18
51316-0141-12 340 g in 1 JAR (51316-141-12) Pramoxine Itch relief CVS 2023-04-25
82046-0620-01 340 g in 1 JAR (82046-620-01) CeraVe Developed with Dermatologists Itch Relief Moisturizing L'Oreal USA Products Inc 2026-05-19
82046-0620-02 453 g in 1 JAR (82046-620-02) CeraVe Developed with Dermatologists Itch Relief Moisturizing L'Oreal USA Products Inc 2026-05-19
82046-0620-03 539 g in 1 JAR (82046-620-03) CeraVe Developed with Dermatologists Itch Relief Moisturizing L'Oreal USA Products Inc 2026-06-11
85284-0008-01 50 g in 1 BOTTLE (85284-008-01) Numbing cream BLOOMWELL GARDENS LLC 2025-08-13
Observed labelers: L'Oreal USA Products Inc (6) · BLOOMWELL GARDENS LLC (1) · CVS (1) · Welmedix LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.